Meribank Biotech , Ltd Intangible Assets

Meribank Biotech , Ltd (4724.TWO) currently reports a intangible assets of $530M as of June 2026. That compares with $570M in the prior-year period — down 6.4% year over year. Use the charts on this page to explore Meribank Biotech , Ltd's intangible assets history and peer comparisons.

Meribank Biotech , Ltd's intangible assets decreased from $570M to $530M — a 6.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Meribank Biotech , Ltd reported $530M in intangible assets as of June 2026. That compares with $570M in the prior-year period — down 6.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $530M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Meribank Biotech , Ltd, and consider following 4724.TWO for alerts when major investors trade the stock.

Meribank Biotech , Ltd is classified in the Healthcare sector. On intangible assets, it currently shows $530M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4724.TWO with unrelated industries.